LONDON (Dow Jones)–Novo Nordisk A/S (NOVO-B.KO) plans to test its diabetes drug Victoza to see whether it could also be used to combat severe obesity, a condition often associated with diabetes.

INTERVIEW: Novo Nordisk To Test Victoza In Anti-Obesity – CEO – WSJ.com.